Literature DB >> 22995748

Endothelin-1: a key pathological factor in pre-eclampsia?

Arjun Jain1.   

Abstract

Endothelin (ET)-1 has been implicated in a diverse range of signalling events in a wide variety of target tissues. Given its potent vasoactive function and the prevalence of hypertension in pre-eclampsia, there has been extensive research on the role of ET-1 in this disorder. Indeed, ET-1 has been suggested to contribute to hypertension in pre-eclampsia. Recently, ET-1 has also been implicated in the induction of both oxidative stress and endoplasmic reticulum stress in pre-eclampsia; each of which has been proposed to contribute to many of the clinical manifestations of this disorder. ET-1 has been shown to activate key signalling molecules that lead to induction of these stress pathways. The use of ET-receptor antagonists could block oxidative and endoplasmic reticulum stress. Hence, further research into the role of ET-1 in pre-eclampsia may lead to the development of possible strategies to circumvent these stress pathways and the associated pathology that occurs in pre-eclampsia. Endothelin (ET)-1 has been implicated in a diverse range of signalling events in a wide variety of target tissues. Given its potent vasoactive function and the prevalence of hypertension in pre-eclampsia, there has been extensive research on the role of ET-1 in this disorder. Indeed, ET-1 has been suggested to contribute to hypertension in pre-eclampsia. Recently, ET-1 has also been implicated in the induction of both oxidative stress and endoplasmic reticulum stress in pre-eclampsia, each of which has been proposed to contribute to many of the clinical manifestations of this disorder. ET-1 has been shown to activate key signalling molecules that lead to induction of these stress pathways. The use of ET-receptor antagonists could block oxidative and endoplasmic reticulum stress. Hence, further research into the role of ET-1 in pre-eclampsia may lead to the development of possible strategies to circumvent these stress pathways and the associated pathology that occurs in pre-eclampsia.
Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995748     DOI: 10.1016/j.rbmo.2012.07.014

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  18 in total

Review 1.  Inhibition of ENaC by endothelin-1.

Authors:  Andrey Sorokin; Alexander Staruschenko
Journal:  Vitam Horm       Date:  2015-03-06       Impact factor: 3.421

2.  Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response.

Authors:  Arjun Jain; Henning Schneider; Eldar Aliyev; Fatimah Soydemir; Marc Baumann; Daniel Surbek; Matthias Hediger; Paul Brownbill; Christiane Albrecht
Journal:  Lab Invest       Date:  2014-06-16       Impact factor: 5.662

Review 3.  Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Curr Hypertens Rep       Date:  2017-09-23       Impact factor: 5.369

Review 4.  Emerging drugs for preeclampsia--the endothelium as a target.

Authors:  Jennifer M Sasser; Sydney R Murphy; Joey P Granger
Journal:  Expert Opin Emerg Drugs       Date:  2015-07-03       Impact factor: 4.191

5.  Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy.

Authors:  Denise C Cornelius; Kedra Wallace; Luissa Kiprono; Pushpinder Dhillon; Janae Moseley; Babbette LaMarca
Journal:  Med J Obstet Gynecol       Date:  2013-09-19

6.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

7.  Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.

Authors:  Wei Wang; Nicholas F Parchim; Takayuki Iriyama; Renna Luo; Cheng Zhao; Chen Liu; Roxanna A Irani; Weiru Zhang; Chen Ning; Yujin Zhang; Sean C Blackwell; Lieping Chen; Lijian Tao; M John Hicks; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

8.  Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.

Authors:  Feng Li; Masao Kakoki; Marcela Smid; Kim Boggess; Jennifer Wilder; Sylvia Hiller; Carol Bounajim; Scott E Parnell; Kathleen K Sulik; Oliver Smithies; Nobuyo Maeda-Smithies
Journal:  Hypertension       Date:  2018-04-02       Impact factor: 10.190

Review 9.  Preeclampsia link to gestational hypoxia.

Authors:  W Tong; D A Giussani
Journal:  J Dev Orig Health Dis       Date:  2019-04-10       Impact factor: 2.401

Review 10.  Regulators of G protein signaling in cardiovascular function during pregnancy.

Authors:  Katherine J Perschbacher; Guorui Deng; Rory A Fisher; Katherine N Gibson-Corley; Mark K Santillan; Justin L Grobe
Journal:  Physiol Genomics       Date:  2018-04-27       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.